SKP-450 inhibits migration and DNA synthesis stimulated by oxidized low density lipoprotein in smooth muscle cells

Eur J Pharmacol. 1999 Nov 3;383(3):373-9. doi: 10.1016/s0014-2999(99)00552-x.

Abstract

This study was carried out to examine the inhibitory effects of SKP-450 (2-[2"(1", 3"-dioxolone)-2-methyl]-4-(2'-oxo-1'-pyrrolidinyl)-6-nitro-2H-1-be nzo pyran), a potassium channel opener, on the proliferation and migration stimulated by oxidized low density lipoprotein (LDL) of cultured smooth muscle cells of Wistar Kyoto rat aorta. SKP-450 (10(-7) and 10(-6) M) as well as probucol (10(-7)-10(-5) M) reduced the production of thiobarbituric acid reactive substances from LDL submitted to CuSO(4) (10 microM). The increased [3H]thymidine incorporation and migration (chemotactic and wound-edge) of the cultured smooth muscle cells in association with increased production of platelet-derived growth factor (PDGF)-BB-like immunoreactivity stimulated by oxidized LDL were significantly reduced by SKP-450 (10(-7)-10(-6) M). Inhibition by SKP-450 of the oxidized LDL-stimulated [3H]thymidine incorporation was antagonized by iberiotoxin (10(-7) M), but not by glibenclamide (10(-6) M), suggestive of mediation of Ca(2+)-activated K(+) channel opening in the action of SKP-450. Taken together, SKP-450 inhibited the proliferation and migration of the smooth muscle cells as well as PDGF production stimulated by oxidized LDL, accompanying with its antiperoxidative action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / cytology
  • Aorta / drug effects
  • Becaplermin
  • Benzopyrans / pharmacology*
  • Cell Movement / drug effects*
  • Cells, Cultured
  • Copper Sulfate / pharmacology
  • DNA / biosynthesis
  • DNA / drug effects*
  • Lipid Peroxidation / drug effects
  • Lipoproteins, LDL / drug effects
  • Lipoproteins, LDL / pharmacology
  • Male
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects*
  • Platelet-Derived Growth Factor / drug effects
  • Platelet-Derived Growth Factor / metabolism
  • Potassium Channels / agonists
  • Potassium Channels / drug effects*
  • Proto-Oncogene Proteins c-sis
  • Pyrrolidinones / pharmacology*
  • Rats
  • Rats, Inbred WKY
  • Thiobarbituric Acid Reactive Substances / metabolism*

Substances

  • Benzopyrans
  • Lipoproteins, LDL
  • Platelet-Derived Growth Factor
  • Potassium Channels
  • Proto-Oncogene Proteins c-sis
  • Pyrrolidinones
  • Thiobarbituric Acid Reactive Substances
  • Becaplermin
  • KR 30450
  • DNA
  • Copper Sulfate